Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma
Open Access
- 22 December 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 168 (3) , 601-612
Abstract
Complex interactions occur between cancer cells and cells in the tumor microenvironment. In this study, the prognostic value of the interplay between tumor–stroma ratio (TSR) and the immune status of tumors in breast cancer patients was evaluated.Keywords
This publication has 35 references indexed in Scilit:
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progressionCancer and Metastasis Reviews, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsiesEuropean Journal of Cancer, 2011
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patientsBritish Journal of Cancer, 2010
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009Annals of Oncology, 2009
- Microenvironmental regulation of cancer developmentCurrent Opinion in Genetics & Development, 2008
- Tumour-Stromal Interactions in Breast Cancer: The Role of Stroma in TumourigenesisTumor Biology, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- The Hallmarks of CancerCell, 2000